1. |
GPR39 |
ENSG00000183840 |
5 |
2 |
1.000 |
1.000 |
G protein-coupled receptor 39 [Source:HGNC Symbol;Acc:HGNC:4496] |
2. |
MAGEA11 |
ENSG00000185247 |
3 |
1 |
1.000 |
- |
MAGE family member A11 [Source:HGNC Symbol;Acc:HGNC:6798] |
3. |
LOC101927237 |
|
10 |
1 |
1.000 |
- |
uncharacterized LOC101927237 |
4. |
PRB3 |
ENSG00000197870, ENSG00000275624 |
1 |
1 |
1.000 |
- |
proline rich protein BstNI subfamily 3 [Source:HGNC Symbol;Acc:HGNC:9339] |
5. |
LOC727924 |
|
1 |
1 |
1.000 |
- |
uncharacterized LOC727924 |
6. |
CCDC79 |
CCDC79 |
1 |
1 |
1.000 |
- |
|
7. |
BCL2A1 |
ENSG00000140379 |
12 |
1 |
1.000 |
- |
BCL2 related protein A1 [Source:HGNC Symbol;Acc:HGNC:991] |
8. |
LOC100133920 |
|
2 |
1 |
1.000 |
- |
methylenetetrahydrofolate dehydrogenase (NADP+ dependent) 1-like pseudogene |
9. |
LOC102724297 |
|
19 |
1 |
1.000 |
- |
uncharacterized LOC102724297 |
10. |
LOC101928002 |
|
15 |
1 |
1.000 |
- |
uncharacterized LOC101928002 |
11. |
OCSTAMP |
ENSG00000149635 |
3 |
1 |
1.000 |
- |
osteoclast stimulatory transmembrane protein [Source:HGNC Symbol;Acc:HGNC:16116] |
12. |
LOC400867 |
|
12 |
1 |
1.000 |
- |
uncharacterized LOC400867 |
13. |
FAAHP1 |
ENSG00000232022 |
3 |
1 |
1.000 |
- |
fatty acid amide hydrolase pseudogene 1 [Source:HGNC Symbol;Acc:HGNC:50679] |
14. |
ALLC |
ENSG00000151360 |
6 |
1 |
1.000 |
- |
allantoicase [Source:HGNC Symbol;Acc:HGNC:17377] |
15. |
HIST2H2AB |
ENSG00000184270 |
13 |
1 |
1.000 |
- |
histone cluster 2 H2A family member b [Source:HGNC Symbol;Acc:HGNC:20508] |
16. |
PMS2CL |
ENSG00000187953 |
16 |
1 |
1.000 |
- |
PMS2 C-terminal like pseudogene [Source:HGNC Symbol;Acc:HGNC:30061] |
17. |
C10orf67 |
ENSG00000179133 |
8 |
1 |
1.000 |
- |
chromosome 10 open reading frame 67 [Source:HGNC Symbol;Acc:HGNC:28716] |
18. |
LINC01257 |
ENSG00000204603 |
2 |
1 |
1.000 |
- |
long intergenic non-protein coding RNA 1257 [Source:HGNC Symbol;Acc:HGNC:26972] |
19. |
LINC01150 |
ENSG00000229671 |
1 |
1 |
1.000 |
- |
long intergenic non-protein coding RNA 1150 [Source:HGNC Symbol;Acc:HGNC:49469] |
20. |
C15orf43 |
C15orf43 |
1 |
1 |
1.000 |
- |
|
21. |
ATP2B2-IT2 |
ENSG00000224771 |
2 |
1 |
1.000 |
- |
ATP2B2 intronic transcript 2 [Source:HGNC Symbol;Acc:HGNC:41310] |
22. |
LOC101928697 |
|
1 |
1 |
1.000 |
- |
uncharacterized LOC101928697 |
23. |
SEPT7-AS1 |
ENSG00000228878 |
1 |
1 |
1.000 |
- |
SEPT7 antisense RNA 1 (head to head) [Source:HGNC Symbol;Acc:HGNC:51153] |
24. |
STEAP3-AS1 |
ENSG00000229867 |
2 |
1 |
1.000 |
- |
STEAP3 antisense RNA 1 [Source:HGNC Symbol;Acc:HGNC:41053] |
25. |
ZG16 |
ENSG00000174992 |
8 |
1 |
1.000 |
- |
zymogen granule protein 16 [Source:HGNC Symbol;Acc:HGNC:30961] |
26. |
LOC101927668 |
|
13 |
1 |
1.000 |
- |
uncharacterized LOC101927668 |
27. |
TSPYL6 |
ENSG00000178021 |
3 |
1 |
1.000 |
- |
TSPY like 6 [Source:HGNC Symbol;Acc:HGNC:14521] |
28. |
CASC6 |
ENSG00000224944 |
4 |
1 |
1.000 |
- |
cancer susceptibility 6 [Source:HGNC Symbol;Acc:HGNC:49076] |
29. |
FAM13A-AS1 |
ENSG00000248019 |
7 |
1 |
1.000 |
- |
FAM13A antisense RNA 1 [Source:HGNC Symbol;Acc:HGNC:19370] |
30. |
OR10H5 |
ENSG00000172519 |
1 |
1 |
1.000 |
- |
olfactory receptor family 10 subfamily H member 5 [Source:HGNC Symbol;Acc:HGNC:15389] |
31. |
LOC101929229 |
|
9 |
1 |
1.000 |
- |
uncharacterized LOC101929229 |
32. |
OGN |
ENSG00000106809 |
28 |
1 |
1.000 |
- |
osteoglycin [Source:HGNC Symbol;Acc:HGNC:8126] |
33. |
VNN2 |
ENSG00000112303 |
5 |
1 |
1.000 |
- |
vanin 2 [Source:HGNC Symbol;Acc:HGNC:12706] |
34. |
FXYD1 |
ENSG00000266964 |
3 |
1 |
1.000 |
- |
FXYD domain containing ion transport regulator 1 [Source:HGNC Symbol;Acc:HGNC:4025] |
35. |
LOC400620 |
|
4 |
1 |
1.000 |
- |
uncharacterized LOC400620 |
36. |
SH2D4B |
ENSG00000178217 |
15 |
0.927 |
0.927 |
- |
SH2 domain containing 4B [Source:HGNC Symbol;Acc:HGNC:31440] |
37. |
FAM9C |
ENSG00000187268 |
3 |
0.894 |
- |
0.894 |
family with sequence similarity 9 member C [Source:HGNC Symbol;Acc:HGNC:18405] |
38. |
LOC100130849 |
|
1 |
0.893 |
- |
0.893 |
phosphorylase kinase gamma subunit 1 pseudogene |
39. |
FLJ40288 |
ENSG00000183470 |
4 |
0.893 |
- |
0.893 |
uncharacterized FLJ40288 [Source:NCBI gene;Acc:286023] |
40. |
CAPNS2 |
ENSG00000256812 |
2 |
0.893 |
- |
0.893 |
calpain small subunit 2 [Source:HGNC Symbol;Acc:HGNC:16371] |
41. |
SLC5A11 |
ENSG00000158865 |
1 |
0.893 |
- |
0.893 |
solute carrier family 5 member 11 [Source:HGNC Symbol;Acc:HGNC:23091] |
42. |
LOC101927919 |
|
3 |
0.893 |
- |
0.893 |
uncharacterized LOC101927919 |
43. |
FAM99A |
ENSG00000205866, ENSG00000281261, ENSG00000281733 |
1 |
0.893 |
- |
0.893 |
family with sequence similarity 99 member A [Source:HGNC Symbol;Acc:HGNC:32368] |
44. |
POM121L2 |
ENSG00000158553 |
3 |
0.893 |
- |
0.893 |
POM121 transmembrane nucleoporin like 2 [Source:HGNC Symbol;Acc:HGNC:13973] |
45. |
CYP8B1 |
ENSG00000180432 |
2 |
0.893 |
- |
0.893 |
cytochrome P450 family 8 subfamily B member 1 [Source:HGNC Symbol;Acc:HGNC:2653] |
46. |
CELF2-AS2 |
ENSG00000237986 |
1 |
0.893 |
- |
0.893 |
CELF2 antisense RNA 2 [Source:HGNC Symbol;Acc:HGNC:44703] |
47. |
SLC26A9 |
ENSG00000174502 |
8 |
0.893 |
- |
0.893 |
solute carrier family 26 member 9 [Source:HGNC Symbol;Acc:HGNC:14469] |
48. |
PROL1 |
PROL1 |
1 |
0.893 |
- |
0.893 |
|
49. |
FCRL5 |
ENSG00000143297 |
1 |
0.893 |
- |
0.893 |
Fc receptor like 5 [Source:HGNC Symbol;Acc:HGNC:18508] |
50. |
FOXH1 |
ENSG00000160973 |
2 |
0.893 |
- |
0.893 |
forkhead box H1 [Source:HGNC Symbol;Acc:HGNC:3814] |
51. |
PROP1 |
ENSG00000175325, ENSG00000274382, ENSG00000280635 |
1 |
0.893 |
- |
0.893 |
PROP paired-like homeobox 1 [Source:HGNC Symbol;Acc:HGNC:9455] |
52. |
HOTS |
|
2 |
0.893 |
- |
0.893 |
H19 opposite tumor suppressor |
53. |
MLIP-IT1 |
ENSG00000236996 |
2 |
0.893 |
- |
0.893 |
MLIP intronic transcript 1 [Source:HGNC Symbol;Acc:HGNC:41461] |
54. |
PATE1 |
ENSG00000171053 |
2 |
0.893 |
- |
0.893 |
prostate and testis expressed 1 [Source:HGNC Symbol;Acc:HGNC:24664] |
55. |
ADAM29 |
ENSG00000168594 |
1 |
0.893 |
- |
0.893 |
ADAM metallopeptidase domain 29 [Source:HGNC Symbol;Acc:HGNC:207] |
56. |
MASP2 |
ENSG00000009724 |
4 |
0.881 |
- |
0.881 |
mannan binding lectin serine peptidase 2 [Source:HGNC Symbol;Acc:HGNC:6902] |
57. |
CCL19 |
ENSG00000172724 |
1 |
0.873 |
- |
0.873 |
C-C motif chemokine ligand 19 [Source:HGNC Symbol;Acc:HGNC:10617] |
58. |
LSAMP-AS1 |
ENSG00000240922 |
2 |
0.867 |
- |
0.867 |
LSAMP antisense RNA 1 [Source:HGNC Symbol;Acc:HGNC:40350] |
59. |
INHBC |
ENSG00000175189 |
2 |
0.866 |
- |
0.866 |
inhibin subunit beta C [Source:HGNC Symbol;Acc:HGNC:6068] |
60. |
LINC01179 |
ENSG00000249500 |
9 |
0.853 |
- |
0.853 |
long intergenic non-protein coding RNA 1179 [Source:HGNC Symbol;Acc:HGNC:49556] |
61. |
IRGM |
ENSG00000237693 |
1 |
0.852 |
- |
0.852 |
immunity related GTPase M [Source:HGNC Symbol;Acc:HGNC:29597] |
62. |
RBMY2FP |
ENSG00000243040 |
6 |
0.852 |
- |
0.852 |
RNA binding motif protein, Y-linked, family 2, member F pseudogene [Source:HGNC Symbol;Acc:HGNC:23891] |
63. |
CIITA |
ENSG00000179583 |
4 |
0.852 |
- |
0.852 |
class II major histocompatibility complex transactivator [Source:HGNC Symbol;Acc:HGNC:7067] |
64. |
BPIFB2 |
ENSG00000078898 |
3 |
0.839 |
- |
0.839 |
BPI fold containing family B member 2 [Source:HGNC Symbol;Acc:HGNC:16177] |
65. |
PRR26 |
ENSG00000180525 |
6 |
0.836 |
- |
0.836 |
proline rich 26 [Source:HGNC Symbol;Acc:HGNC:30724] |
66. |
EPHA1 |
ENSG00000146904, ENSG00000284816 |
6 |
0.834 |
- |
0.834 |
EPH receptor A1 [Source:HGNC Symbol;Acc:HGNC:3385] |
67. |
SNORA4 |
ENSG00000263776 |
1 |
0.833 |
- |
0.833 |
small nucleolar RNA, H/ACA box 4 [Source:HGNC Symbol;Acc:HGNC:32587] |
68. |
OIT3 |
ENSG00000138315 |
41 |
0.833 |
- |
0.833 |
oncoprotein induced transcript 3 [Source:HGNC Symbol;Acc:HGNC:29953] |
69. |
HS3ST2 |
ENSG00000122254 |
29 |
0.832 |
0.832 |
- |
heparan sulfate-glucosamine 3-sulfotransferase 2 [Source:HGNC Symbol;Acc:HGNC:5195] |
70. |
BCAS1 |
ENSG00000064787 |
63 |
0.832 |
- |
0.832 |
breast carcinoma amplified sequence 1 [Source:HGNC Symbol;Acc:HGNC:974] |
71. |
TMED6 |
ENSG00000157315 |
9 |
0.83 |
- |
0.830 |
transmembrane p24 trafficking protein 6 [Source:HGNC Symbol;Acc:HGNC:28331] |
72. |
PNLIPRP2 |
ENSG00000266200 |
8 |
0.826 |
- |
0.826 |
pancreatic lipase related protein 2 (gene/pseudogene) [Source:HGNC Symbol;Acc:HGNC:9157] |
73. |
BEST1 |
ENSG00000167995 |
3 |
0.819 |
- |
0.819 |
bestrophin 1 [Source:HGNC Symbol;Acc:HGNC:12703] |
74. |
LOC100506985 |
|
4 |
0.796 |
- |
0.796 |
uncharacterized LOC100506985 |
75. |
IGSF21 |
ENSG00000117154 |
24 |
0.795 |
0.795 |
- |
immunoglobin superfamily member 21 [Source:HGNC Symbol;Acc:HGNC:28246] |
76. |
DKFZp686K1684 |
|
14 |
0.776 |
- |
0.776 |
uncharacterized LOC440034 |
77. |
PGA5 |
ENSG00000256713 |
7 |
0.767 |
0.767 |
- |
pepsinogen 5, group I (pepsinogen A) [Source:HGNC Symbol;Acc:HGNC:8887] |
78. |
LOC100131496 |
|
22 |
0.766 |
- |
0.766 |
uncharacterized LOC100131496 |
79. |
CDKN2B-AS1 |
ENSG00000240498 |
7 |
0.763 |
- |
0.763 |
CDKN2B antisense RNA 1 [Source:HGNC Symbol;Acc:HGNC:34341] |
80. |
VSTM2A-OT1 |
ENSG00000224223 |
12 |
0.757 |
0.757 |
- |
VSTM2A overlapping transcript 1 [Source:HGNC Symbol;Acc:HGNC:50770] |
81. |
KCTD19 |
ENSG00000168676 |
17 |
0.749 |
0.749 |
- |
potassium channel tetramerization domain containing 19 [Source:HGNC Symbol;Acc:HGNC:24753] |
82. |
LOC101928535 |
|
50 |
0.748 |
- |
0.748 |
uncharacterized LOC101928535, transcript variant 2 |
83. |
MUC7 |
ENSG00000171195 |
13 |
0.735 |
- |
0.735 |
mucin 7, secreted [Source:HGNC Symbol;Acc:HGNC:7518] |
84. |
CXorf65 |
ENSG00000204165 |
2 |
0.727 |
- |
0.727 |
chromosome X open reading frame 65 [Source:HGNC Symbol;Acc:HGNC:33713] |
85. |
MARVELD2 |
ENSG00000152939, ENSG00000274671 |
6 |
0.726 |
- |
0.726 |
MARVEL domain containing 2 [Source:HGNC Symbol;Acc:HGNC:26401] |
86. |
LSP1P3 |
ENSG00000162685 |
7 |
0.722 |
0.722 |
- |
LSP1 pseudogene 3 [Source:HGNC Symbol;Acc:HGNC:39718] |
87. |
FLJ36777 |
|
15 |
0.71 |
- |
0.710 |
uncharacterized LOC730971 |
88. |
TTC39A |
ENSG00000085831 |
22 |
0.706 |
0.706 |
- |
tetratricopeptide repeat domain 39A [Source:HGNC Symbol;Acc:HGNC:18657] |
89. |
PRRG2 |
ENSG00000126460 |
16 |
0.701 |
- |
0.701 |
proline rich and Gla domain 2 [Source:HGNC Symbol;Acc:HGNC:9470] |